Your browser is no longer supported. Please, upgrade your browser.
Settings
LCI Lannett Company, Inc. daily Stock Chart
LCI [NYSE]
Lannett Company, Inc.
Index- P/E- EPS (ttm)-0.09 Insider Own2.10% Shs Outstand37.67M Perf Week-5.02%
Market Cap783.54M Forward P/E7.18 EPS next Y2.90 Insider Trans1.28% Shs Float27.26M Perf Month4.26%
Income-2.70M PEG- EPS next Q0.75 Inst Own98.10% Short Float54.41% Perf Quarter-17.46%
Sales667.10M P/S1.17 EPS this Y-70.30% Inst Trans0.02% Short Ratio23.50 Perf Half Y10.64%
Book/sh15.03 P/B1.38 EPS next Y-9.75% ROA-0.20% Target Price27.50 Perf Year-32.16%
Cash/sh4.10 P/C5.07 EPS next 5Y-7.42% ROE-0.50% 52W Range16.75 - 39.99 Perf YTD-5.67%
Dividend- P/FCF8.44 EPS past 5Y159.60% ROI6.80% 52W High-47.86% Beta2.71
Dividend %- Quick Ratio2.00 Sales past 5Y39.60% Gross Margin48.90% 52W Low24.48% ATR0.77
Employees1149 Current Ratio2.60 Sales Q/Q1.20% Oper. Margin12.70% RSI (14)49.24 Volatility3.09% 3.60%
OptionableYes Debt/Eq1.69 EPS Q/Q362.90% Profit Margin-0.40% Rel Volume0.34 Prev Close20.80
ShortableYes LT Debt/Eq1.54 EarningsAug 22 AMC Payout- Avg Volume631.20K Price20.85
Recom2.40 SMA20-1.20% SMA502.67% SMA200-4.84% Volume40,224 Change0.24%
Jun-29-16Initiated Deutsche Bank Hold $26
Mar-24-16Downgrade Canaccord Genuity Buy → Sell $28 → $18
Feb-04-16Upgrade Craig Hallum Hold → Buy
Nov-05-15Downgrade Craig Hallum Buy → Hold
Sep-03-15Reiterated ROTH Capital Buy $61 → $68
Jul-21-15Initiated Susquehanna Positive
Feb-05-15Reiterated ROTH Capital Buy $54 → $61
Nov-24-14Reiterated ROTH Capital Buy $66 → $60
Nov-04-14Reiterated ROTH Capital Buy $53 → $66
Nov-04-14Reiterated Canaccord Genuity Buy $55 → $73
Nov-04-14Downgrade Oppenheimer Outperform → Perform $53
Oct-13-14Reiterated Oppenheimer Outperform $51 → $53
Jul-15-14Reiterated Oppenheimer Outperform $49 → $52
May-06-14Resumed Canaccord Genuity Buy $55
Feb-10-14Reiterated Canaccord Genuity Buy $29 → $55
Feb-07-14Reiterated Oppenheimer Outperform $41 → $45
Sep-11-13Reiterated Oppenheimer Outperform $15 → $20
May-23-13Initiated Needham Buy $15
Feb-08-13Reiterated Oppenheimer Outperform $6 → $9
Sep-08-11Reiterated Oppenheimer Outperform $7 → $6
Jul-24-17 04:57PM  ETFs with exposure to Lannett Co., Inc. : July 24, 2017 Capital Cube
Jul-17-17 09:01AM  Fox Rothschild partner becomes general counsel of local drug manufacturer American City Business Journals
07:20AM  Corporate News Blog - Lannett Co. Receives Approval for Cyproheptadine Hydrochloride Syrup Accesswire
06:53AM  Lannett Appoints Samuel H. Israel As General Counsel PR Newswire
Jul-14-17 06:53AM  Lannett Receives Approval For Cyproheptadine Hydrochloride Syrup, 2 mg/5 mL PR Newswire +6.57%
Jul-12-17 02:46PM  ETFs with exposure to Lannett Co., Inc. : July 12, 2017 Capital Cube
Jul-04-17 08:57AM  Lannett Co., Inc. breached its 50 day moving average in a Bullish Manner : LCI-US : July 4, 2017 Capital Cube
Jun-28-17 08:15AM  Corporate News Blog - Lannett Receives Approval for Additional Dosage Strengths of Hydrocodone Bitartrate and Acetaminophen Tablets USP Accesswire
Jun-26-17 06:51AM  Lannett Receives Approval For Additional Dosage Strengths Of Hydrocodone Bitartrate And Acetaminophen Tablets USP PR Newswire
Jun-22-17 06:53AM  Lannett Receives Approval For Hydrocodone Bitartrate and Acetaminophen Tablets USP, 5 mg/300 mg, 7.5 mg/300 mg And 10 mg/300 mg PR Newswire
Jun-20-17 06:52AM  Lannett Names Patrick G. LePore To Board of Directors PR Newswire
Jun-19-17 03:38PM  ETFs with exposure to Lannett Co., Inc. : June 19, 2017 Capital Cube
08:15AM  Featured Company News - Lannett Announces Approval for Amantadine Hydrochloride Capsules USP, 100 mg; Set to Launch Before the Flu Season Accesswire
06:53AM  Lannett Receives Approval For Niacin Extended-Release Tablets USP, 500 Mg And 1000 Mg PR Newswire
Jun-16-17 11:49AM  Lannett Co., Inc. :LCI-US: Earnings Analysis: Q3, 2017 By the Numbers : June 16, 2017 Capital Cube
06:53AM  Lannett Announces Approval For Amantadine Hydrochloride Capsules USP, 100 mg PR Newswire
May-26-17 06:53AM  Lannett Company's Chief Executive Officer Receives High Rating PR Newswire
May-16-17 06:52AM  Lannett Announces Approval For Levocetirizine Dihydrochloride Oral Solution, 2.5 mg/5 mL (0.5 mg/mL) PR Newswire
May-09-17 06:53AM  Lannett Voluntarily Pays Down Remaining $25 Million Principal Balance Of Revolving Credit Facility PR Newswire
May-05-17 05:08PM  Lannett Co., Inc. Value Analysis (NYSE:LCI) : May 5, 2017 Capital Cube
May-04-17 02:16PM  Edited Transcript of LCI earnings conference call or presentation 2-May-17 8:30pm GMT Thomson Reuters StreetEvents
08:53AM  Lannett Co., Inc. breached its 50 day moving average in a Bearish Manner : LCI-US : May 4, 2017 Capital Cube
May-03-17 01:07PM  Here's Why Lannett Company, Inc. Is Having a Lousy Day Motley Fool -18.60%
12:46PM  Biotech And Pharma Industry And Stock News Investor's Business Daily
08:53AM  Perrigo Stock Sliding on DOJ Search TheStreet.com
May-02-17 07:41PM  Lannett misses Street 3Q forecasts Associated Press
04:15PM  Lannett Reports Fiscal 2017 Third-Quarter Financial Results PR Newswire
Apr-28-17 06:54AM  Lannett To Participate At Three Investor Conferences In May PR Newswire
Apr-25-17 06:54AM  Lannett To Report Fiscal 2017 Third-Quarter Financial Results, Host Conference Call On Tuesday, May 2 PR Newswire
Apr-24-17 09:40AM  Lawsuit for Investors in NYSE: LCI Shares against Lannett Company, Inc Announced by Shareholders Foundation Accesswire
Apr-10-17 04:31PM  Akorn Acquisition Talks Send Generic Drugmakers Into Orbit Investor's Business Daily +10.59%
Apr-04-17 08:23AM  Lannett Co., Inc. breached its 50 day moving average in a Bearish Manner : LCI-US : April 4, 2017 Capital Cube
08:23AM  Lannett Co., Inc. breached its 50 day moving average in a Bearish Manner : LCI-US : April 4, 2017
Apr-03-17 12:14PM  Lannett Refuses to Go Lower TheStreet.com
12:14PM  Lannett Refuses to Go Lower
Mar-30-17 06:53AM  Lannett Voluntarily Pays Down Additional $25 Million Of Revolving Credit Facility PR Newswire
Mar-29-17 11:31AM  Trading Five Volatility Squeeze Plays
Mar-27-17 06:54AM  Lannett Announces Passing Of Former Chairman And Chief Executive Officer William Farber PR Newswire
Mar-24-17 02:43PM  3 Top Generic Drug Companies to Buy in 2017 Motley Fool
02:43PM  3 Top Generic Drug Companies to Buy in 2017 at Motley Fool
Mar-21-17 09:40AM  Is Lannett (LCI) a Great Stock for Value Investors? Zacks
09:40AM  Is Lannett (LCI) a Great Stock for Value Investors?
Mar-20-17 08:19AM  Lannett Co., Inc. breached its 50 day moving average in a Bearish Manner : LCI-US : March 20, 2017 Capital Cube
08:19AM  Lannett Co., Inc. breached its 50 day moving average in a Bearish Manner : LCI-US : March 20, 2017
Mar-10-17 09:30AM  The Zacks Analyst Blog Highlights: Inogen, OraSure Technologies, Lannett and Cardiovascular Systems Zacks
09:30AM  The Zacks Analyst Blog Highlights: Inogen, OraSure Technologies, Lannett and Cardiovascular Systems
Feb-27-17 06:53AM  Lannett To Participate At Four Upcoming Investor Conferences PR Newswire
Feb-23-17 06:53AM  Lannett Announces Addition To Management Team PR Newswire
Feb-22-17 11:25AM  FDA gives Lannett more time to make its case for ADHD drug at bizjournals.com
06:54AM  Lannett Provides Further Update On Methylphenidate ER Tablets PR Newswire
Feb-16-17 10:13AM  Will Lannett (LCI) Continue to Surge Higher?
Feb-13-17 12:55PM  Weekly CEO Buys Highlights
Feb-08-17 05:18PM  CEO Buys Shares of Lannett
01:04PM  LANNETT CO INC Financials
Feb-07-17 11:23AM  Lannett Co., Inc. :LCI-US: Earnings Analysis: Q2, 2017 By the Numbers : February 7, 2017
10:22AM  Will Q4 Earnings Hold a Surprise for DaVita (DVA) Stock?
09:15AM  Board Member at Beleaguered Burrito Chain Buys Shares After Barrons Releases Grim Cover Story, Plus Other Noteworthy Insider Trading Activity at Insider Monkey
06:54AM  Lannett Announces Successful Completion Of ERP System Extraction PR Newswire
Feb-06-17 08:20AM  Affimed (AFMD) Shows Strength: Stock Moves 8.1% Higher
08:00AM  AcelRx Pharmaceuticals (ACRX) in Focus: Stock Rises 5.3%
Feb-03-17 08:57AM  LANNETT CO INC Files SEC form 10-Q, Quarterly Report -8.06%
Feb-02-17 04:16PM  LANNETT CO INC Files SEC form 8-K, Results of Operations and Financial Condition
Feb-01-17 10:39PM  Edited Transcript of LCI earnings conference call or presentation 1-Feb-17 9:30pm GMT
05:48PM  Lannett tops Street 2Q forecasts
04:15PM  Lannett Reports Fiscal 2017 Second-Quarter Financial Results PR Newswire
07:07AM  Q2 2017 Lannett Company Inc Earnings Release - After Market Close
Jan-30-17 01:42PM  5 Earnings Short-Squeeze Trade Ideas
Jan-25-17 08:11PM  SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of Lannett Company, Inc. -LCI PR Newswire
05:03PM  LANNETT CO INC Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders
06:54AM  Lannett To Report Fiscal 2017 Second-Quarter Financial Results, Host Conference Call On Wednesday, February 1 PR Newswire
Jan-23-17 03:05PM  Robbins Arroyo LLP: Lannett Company, Inc. (LCI) Misled Shareholders According to a Recently Filed Class Action Business Wire
08:27AM  Lannett Voluntarily Pays Down $75 Million Of Revolving Credit Facility PR Newswire
Jan-19-17 05:34PM  LANNETT CO INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
03:03PM  Lifshitz & Miller Law Firm Announces Investigation of Ally Financial Inc., Amphastar Pharmaceuticals, Inc., Lannett Company, Inc., Live Ventures Incorporated, MiMedx Group, Inc., Seattle Genetics, Inc., Teligent, Inc., TerraVia Holdings, In PR Newswire
Jan-13-17 02:49PM  Harwood Feffer LLP Announces Investigation of Lannett Company Inc. PR Newswire
11:40AM  Bernstein Liebhard LLP Announces That Only Four Days Remain To File A Motion For Lead Plaintiff In A Class Action Suit Against Lannett Company, Inc. PR Newswire
10:47AM  UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Lannett Company, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 Business Wire
10:10AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lannett Company Inc. (LCI) and Lead Plaintiff Deadline: January 17, 2017 GlobeNewswire
Jan-12-17 05:10PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Lannett Company, Inc. - LCI PR Newswire
Jan-11-17 09:45AM  Deadline in Lawsuit for Investors in Lannett Company, Inc. (NYSE: LCI) Shares Announced by Shareholders Foundation Accesswire -5.29%
Jan-09-17 04:57PM  SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Lannett Company, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
12:42PM  LCI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Lannett Company, Inc. and a Lead Plaintiff Deadline of January 17, 2017 Business Wire
Jan-07-17 06:00AM  DEADLINE ALERT: Brower Piven Reminds Investors Of The January 17, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In Lannett Company, Inc. To Contact The Firm Business Wire
Jan-06-17 10:35AM  Lannett Co., Inc. Value Analysis (NYSE:LCI) : January 6, 2017
Jan-05-17 06:12PM  Lannet's Lopinavir, Ritonavir Approved to Treat HIV in US
10:09AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lannett Company Inc. (LCI) and Lead Plaintiff Deadline: January 17, 2017 Accesswire
08:11AM  Lannett Co., Inc. breached its 50 day moving average in a Bullish Manner : LCI-US : January 5, 2017
Jan-03-17 03:01PM  EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Lannett Company, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
02:46PM  LCI LOSS NOTICE: Rosen Law Firm Reminds Lannett Company, Inc. Investors of Important January 17 Deadline in Class Action Filed by Firm - LCI GlobeNewswire
01:11PM  Lannett Announces Approval For Lopinavir And Ritonavir Oral Solution USP, 80 Mg/20 Mg Per mL PR Newswire
11:57AM  LCI INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Lannett Company, Inc. and a Lead Plaintiff Deadline of January 17, 2017 PR Newswire
Dec-29-16 09:15PM  INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Lannett Company, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
10:07AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lannett Company Inc. (LCI) and Lead Plaintiff Deadline: January 17, 2017 Accesswire
Dec-27-16 02:20PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Lannett Company, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
12:31PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Lannett Company, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 Business Wire
Dec-24-16 01:14PM  SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Lannett Company, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
Dec-23-16 08:03PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lannett Company, Inc. of Class Action Lawsuit and Upcoming Deadline - LCI Accesswire
Dec-22-16 03:08PM  EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Lannett Company, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire -8.84%
10:07AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Lannett Company Inc. (LCI) and Lead Plaintiff Deadline: January 17, 2017 Accesswire
Dec-21-16 12:25PM  INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Lannett Company, Inc. and Encourages Investors with Losses to Contact the Firm Accesswire
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. It offers solid oral, extended release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages. The company provides its products for various medical indications comprising glaucoma, muscle relaxant, migraine, anesthetic, congestive heart failure, gastrointestinal, cardiovascular, thyroid deficiency, central nervous system, urinary, dryness of the mouth, gout, hypertension, and gallstone. It also manufactures active pharmaceutical ingredients. Lannett Company, Inc. markets its products under the Diamox, Fioricet, Fiorinal, Lanoxin, MiraLAX, Imdur, Levoxyl/Synthroid, Metadate CD, Concerta, Procardia, Prilosec, Ditropan, Protonix, Salagen, Dyazide, and Actigall brands. The company sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with JSP, Summit Bioscience LLC, HEC Pharm Group, and Pharma Pass II LLC. Lannett Company, Inc. was founded in 1942 and is based in Philadelphia, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BEDROSIAN ARTHUR PCEOFeb 06Buy20.0010,000200,000688,909Feb 06 05:14 PM
FARBER DAVID10% OwnerDec 13Sale25.002005,0001,930,870Dec 15 04:28 PM
FARBER DAVID10% OwnerDec 09Sale25.306,000151,8001,931,070Dec 15 04:28 PM
FARBER DAVID10% OwnerDec 02Sale25.003,80095,0001,937,070Dec 05 04:29 PM
FARBER JEFFREYDirectorNov 07Option Exercise6.895,00034,4502,438,826Nov 08 05:49 PM
Landis G. MichaelPrincipal Accounting OfficerSep 15Option Exercise13.864,33460,0696,461Sep 16 05:22 PM
Landis G. MichaelPrincipal Accounting OfficerSep 15Sale32.304,334139,9882,127Sep 16 05:22 PM
BEDROSIAN ARTHUR PCEOSep 09Option Exercise4.6495,325442,289676,995Sep 12 04:06 PM
Maher James M.DirectorSep 01Sale33.911,47850,11920,320Sep 01 05:04 PM
Landis G. MichaelPrincipal Accounting OfficerAug 31Option Exercise10.806,33368,3756,913Sep 01 05:03 PM
Landis G. MichaelPrincipal Accounting OfficerAug 31Sale33.416,786226,7162,127Sep 01 05:03 PM